We are monitoring the impact of COVID-19 on Latin America Point of Care (POC) Diagnostics/Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1484
Share on
Share on

Latin America Point of Care (POC) Diagnostics/Testing Market Research Report – Segmented By Product, End-User, Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Size, Share, Trends, Growth Opportunities Assessment, Industry Forecast | 2021 to 2026

Pulished: April, 2021
ID: 1484
Pages: 138

Latin America POC Diagnostics Market Size (2021 to 2026)

The size of the Point of Care (POC) Diagnostics/Testing Market in Latin America was worth USD 2.98 billion in 2021 and estimated to reach USD 4.74 billion by the end of 2026, with a CAGR of 9.68%.

The introduction of cost-effective technologies related to the efficient and accurate detection, diagnosis, and surveillance of disease and government initiatives to control the spread of disease and provide better health facilities, will serve as an essential factor in the course of the forecast period. Besides, the increase in the geriatric population, which is more prone to infections and other diseases, is expected to stimulate demand for home health care and independent living diagnostic and monitoring devices. Besides, adoption of a sedentary lifestyle by the young and middle-aged population is believed to contribute to the prevalence of diabetes, heart problems, drug addiction, and STDs in developing countries, in addition to the expected prevalence presence of chronic and endemic diseases such as Chagas in less developed regions to increase market potential. Increasingly concerned about the increasing prevalence of infectious diseases in Latin America, several health organizations and governments have put detection programs and plans to control and eradicate these diseases. Gradually growing economies, increasing the purchasing power of the population, high prevalence of the disease, and increased awareness of medicine are expected to push the point-of-care diagnostics market in Latin America in the forecast period.

The high price of molecular test kits is expected to hamper the growth of the market. Molecular-based test kits play an essential role in the diagnosis of infectious diseases. However, the high price of molecular test kits leads to their low adoption, especially in emerging countries. The non-reimbursement of certain infectious diseases is also expected to limit the growth of the market.

COVID-19 Impact on this market

The increasing prevalence of various chronic and infectious diseases such as heart disease, hepatitis, cancer, gastrointestinal, respiratory, and sexually transmitted diseases (STDs) play a vital role in the growth of the point-of-care diagnostics market. However, the recent outbreak of coronavirus disease (COVID-19) has led to the rapid expansion of the region's POC diagnostics market. In April 2020, Vale S.A., a Brazilian multinational, purchased 5.5 million new quick test kits for the coronavirus (COVID-19) to help the Brazilian government fight the country's spread of the disease. Additionally, Hi Technologies, a Brazilian healthcare technology startup specializing in laboratory examination equipment, produces batches of rapid tests to diagnose COVID-19. Amid the ongoing pandemic, the widespread adoption of point-of-care diagnostic test kits in the Latin American region has increased dramatically, according to WHO advice.

This market research report on the Latin America POC Diagnostics Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast until 2025.

By Product: 

  • Infectious Diseases
  • Cardiac Markers
  • Oncology Markers
  • OTC Diagnostic Tests
  • Drugs Of Abuse
  • Blood Gas Testing
  • Fertility Testing
  • Urinalysis
  • Coagulation
  • Hematology
  • Glucose Monitoring
  • Ambulatory Chemistry
  • Decentralized Clinical Chemistry 

By End-User: 

  • Clinics
  • Hospitals
  • Home Healthcare
  • Ambulatory Care Settings
  • Laboratories

By Country: 

  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Rest of Latin America

Regionally, emerging markets such as Brazil offer high growth potential for companies involved in developing and distributing point-of-care diagnostic devices. Increasing initiatives by market players, a growing patient population base, and a rise in the number of partnerships and joint ventures among point-of-care providers are the key factors driving the growth of the point-of-care diagnostics market in emerging countries.

The Latin American region has suffered a significant epidemiological burden of infectious diseases such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), Ebola, chikungunya, avian flu, swine flu, Zika, and COVID-19 in recent years. The increasing prevalence of several infectious diseases in low-economy countries like Haiti, Bolivia, Guatemala, and others and the rapid spread of STDs in the developing economies of Brazil, Mexico, and Chile, should stimulate the need for POC Diagnostics superior to the prognosis period. Besides, the number of government initiatives for early detection and diagnosis of the disease and support for establishing health check-ups and camps is expected to increase demand. Brazil dominated the POC diagnostics industry in Latin America in 2019, with an estimated revenue share of over 41%. The presence of healthcare reforms, such as the Unified Healthcare System, is expected to boost the market growth in Brazil. The high prevalence of infections and the rapid increase in diabetes, cancer, and heart conditions in the country are expected to increase POC diagnostics demand. Chile is estimated to experience potential development in the coming years due to the emergence of the Zika virus and a greater prevalence of Chagas disease. The evolution of the economy to develop the health care infrastructure, control and reduce the incidence of target diseases, and prevent the emergence of new diseases, is estimated to boost the demand for POC diagnostics in this country.

Key players dominating the Latin American POC testing market are Abbott Laboratories, Inc., Danaher Corporation, Roche Diagnostics Limited, BioMerieux, Siemens Healthcare, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., and PTS Diagnostics.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Infectious Diseases             

                                5.1.3 Cardiac Markers   

                                5.1.4 Oncology Markers

                                5.1.5 OTC Diagnostic Tests          

                                5.1.6 Drugs Of Abuse    

                                5.1.7 Blood Gas Testing

                                5.1.8 Fertility Testing     

                                5.1.9 Urinalysis 

                                5.1.10 Coagulation         

                                5.1.11 Hematology         

                                5.1.12 Glucose Monitoring          

                                5.1.13 Ambulatory Chemistry    

                                5.1.14 Decentralized Clinical Chemistry 

                                5.1.15 Others   

                                5.1.16 Y-o-Y Growth Analysis, By Product              

                                5.1.17 Market Attractiveness Analysis, By Product            

                                5.1.18 Market Share Analysis, By Product             

                5.2 End-Users                   

                                5.2.1 Introduction           

                                5.2.2 Clinics        

                                5.2.3 Hospitals  

                                5.2.4 Home Healthcare 

                                5.2.5 Ambulatory Care Settings 

                                5.2.6 Laboratories           

                                5.2.7 Others      

                                5.2.8 Y-o-Y Growth Analysis, By End-Users           

                                5.2.9 Market Attractiveness Analysis, By End-Users          

                                5.2.10 Market Share Analysis, By End-Users        

                5.3 Mode of Delivery                     

                                5.3.1 Introduction           

                                5.3.2 OTC            

                                5.3.3 Prescription            

                                5.3.4 Y-o-Y Growth Analysis, By Mode of Delivery             

                                5.3.5 Market Attractiveness Analysis, By Mode of Delivery            

                                5.3.6 Market Share Analysis, By Mode of Delivery             

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By End-Users

                                                6.1.3.4 By Mode of Delivery

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By End-Users

                                                6.1.4.4 By Mode of Delivery

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By End-Users

                                                6.1.5.4 By Mode of Delivery

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Abbott Laboratories               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Danaher Corporation                             

                8.3 Roche Diagnostics                    

                8.4 BioMerieux                

                8.5 Siemens Healthcare                

                8.6 Beckman Coulter                     

                8.7 Becton Dickinson and Company                        

                8.8 Johnson & Johnson                 

                8.9 Johnson & Johnson                 

                8.10 PTS Diagnostics                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  2. Latin America Infectious Diseases Market By Region, From 2021 to 2026 (USD Billion)
  3. Latin America Cardiac Markers Market By Region, From 2021 to 2026 (USD Billion)
  4. Latin America Oncology Markers Market By Region, From 2021 to 2026 (USD Billion)
  5. Latin America OTC Diagnostic Tests Market By Region, From 2021 to 2026 (USD Billion)
  6. Latin America Drugs Of Abuse Market By Region, From 2021 to 2026 (USD Billion)
  7. Latin America Blood Gas Testing Market By Region, From 2021 to 2026 (USD Billion)
  8. Latin America Fertility Testing Market By Region, From 2021 to 2026 (USD Billion)
  9. Latin America Urinalysis Market By Region, From 2021 to 2026 (USD Billion)
  10. Latin America Coagulation Market By Region, From 2021 to 2026 (USD Billion)
  11. Latin America Hematology Market By Region, From 2021 to 2026 (USD Billion)
  12. Latin America Glucose Monitoring Market By Region, From 2021 to 2026 (USD Billion)
  13. Latin America Ambulatory Chemistry Market By Region, From 2021 to 2026 (USD Billion)
  14. Latin America Decentralized Clinical Chemistry Market By Region, From 2021 to 2026 (USD Billion)
  15. Latin America Others Market By Region, From 2021 to 2026 (USD Billion)
  16. Latin America Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  17. Latin America Clinics Market By Region, From 2021 to 2026 (USD Billion)
  18. Latin America Hospitals Market By Region, From 2021 to 2026 (USD Billion)
  19. Latin America Home Healthcare Market By Region, From 2021 to 2026 (USD Billion)
  20. Latin America Ambulatory Care Settings Market By Region, From 2021 to 2026 (USD Billion)
  21. Latin America Laboratories Market By Region, From 2021 to 2026 (USD Billion)
  22. Latin America Others Market By Region, From 2021 to 2026 (USD Billion)
  23. Latin America Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)
  24. Latin America OTC Market By Region, From 2021 to 2026 (USD Billion)
  25. Latin America Prescription Market By Region, From 2021 to 2026 (USD Billion)
  26. Brazil Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  27. Brazil Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  28. Brazil Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)
  29. Argentina Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  30. Argentina Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  31. Argentina Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)
  32. Mexico Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  33. Mexico Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  34. Mexico Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)
  35. Rest of Latin America Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  36. Rest of Latin America Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  37. Rest of Latin America Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample